絞り込み

17695

広告

Optimisation of novel 4, 8-disubstituted dihydropyrimido[5,4-][1,4]oxazine derivatives as potent GPR 119 agonists.

著者 Fang Y , Zhang S , Li M , Xiong L , Tu L , Xie S , Jin Y , Liu Y , Yang Z , Liu R
J Enzyme Inhib Med Chem.2020 Dec ; 35(1):50-58.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (51view , 0users)

Full Text Sources

Medical

GPR119 is a promising target for discovery of anti-type 2 diabetes mellitus agents. We described the optimisation of a novel series of pyrimido[5,4-][1,4]oxazine derivatives as GPR119 agonists. Most designed compounds exhibited good agonistic activities. Among them, compound and demonstrated the potent EC values (13 and 12 nM, respectively) and strong inherent activities. Moreover, significant hypoglycaemic effect of compound was observed by reducing the blood glucose AUC at the dose of 30 mg/kg, which is stronger than Vildagliptin (23.4% reduction vs. 17.9% reduction).
PMID: 31656107 [PubMed - in process]
印刷用ページを開く Endnote用テキストダウンロード